In order to mimic the human metabolic pathway ofcyclosporin A (CyA) a total of 28 bacterial and 72 fungal strains was screened for their ability to transform CyA. Among3 bacteria and ll 
sp. (ATCC53771) achieved the best transformation rate (5.4%). Furthermore, the two iV-demethylated minor products [Leu4]CyA (3.2%) and [Leu9]CyA (4.7%) were isolated, both known as minor natural metabolites and the first one also as a human biotransformation product. Microbial conversion of CyA using the actinomycete Sebekia benihana (NRRL 11111) yielded None of the biotransformation products showed a better immunosuppressive effect than CyA, although in various cases the cyclophilin binding affinity was comparable to that of CyA.
In the course of the human metabolic pathway, CyA is predominately hydroxylated at the terminal C-atom of amino acid 1 to the corresponding allyl alcohol
OHyMeBmt^CyA (designated OL-17)1}. Furthermore, hydroxylation takes place at the y-position of the Nmethylleucines 4, 6 and 9, as well as N-demethylation of the 7V-methylleucine 41}. The aim of the present study was to mimic the humanmetabolic pathway of CyA using the transformation talent of microorganisms.
Microbial hydroxylation yielding regio-and stereoselective pure compoundsin a one step reaction2), represents an useful alternative to chemical synthesis. In the case ofOL-17, for instance, chemical synthesis is a multi step reaction and yields an isomeric mixture3), laborious to separate. The use of entire cells instead of isolated enzymes for hydroxylation renders the regeneration of costly co factors redundant4). While in the field of steroids intensive research on stereoselective hydroxylation5) has been performed, there are only a few reports on the biotransformation of macrocyclic molecules until now6~8). Therefore, a series of microorganisms with known hydroxylation capability was selected for a broad screening.
In order to investigate the type of biotransformation, HPLC-analysis using diode array detection was combined with LC-MSmeasurements. Derivatives, identified with these methods, were isolated out of larger scale fermentations, followed by the elucidation of their structures using NMRtechniques. 781 The transformation products were tested for immunosuppressive activity, binding affinity to cyclophilin A and antifungal effects. detected at 210nm (DAD).
Materials and Methods

LC-MS Electrospray ionization mass spectrometry (ESI-MS)
was performed on a Finnigan TSQ 7000 triple quadrupole mass spectrometer. The instrument was con- AUG. 1996 trolled and data were analyzed using ICIS software (Finnigan).
The electrostatic-spray ion source was operated at 4.5kV and atmosphere-vacuum transfer capillary was heated at 220°C. The column effluent was 
Isolation of the Biotransformation Products of NRRL 11111
The myceliumwas separated from the culture medium and the resulting culture filtrate (13 liters) was extracted three times with 1,2-dichloroethane using 1.5 liter at each extraction. The combined organic solutions were evaporated under vacuum at 40°C. The crude residue was subjected to Sephadex LH-20 gel filtration using methanol as eluent. Those fractions containing the cyclosporin derivatives (525mg) were pooled and chromatographed on silica gel (0.04~0.063 mm, Merck) using CHCl3/MeOHas eluent. Repeated chromatography using the same system yielded pure lc (HOmg) as an amorphous white powder, mp 150~l53°C,
From large scale fermentations (6200 liter) the more polar side fractions obtained in the purification process were further separated by repeated silica gel chromatography (0.04~0.063 mm) using acetone -hexane 2 : 1 and ter^butylmethyl ether-MeOH-H2O 90: 9 : 1 as eluent, respectively. The first fraction contained Id, which was further purified by decolorizing with charcoal yielding the pure compound (6.0g) as an amorphous white powder, mp 162-164°C, [<x]£°-211°(c 0.5 in CHC13). The later fractions from the above silica gel column chromatography yielded after being decolorized with charcoal 890mg le as an amorphous white powder, mp were associated with the methyl groups of MeLeu4. One of the /?-methylene protons of MeLeu4 is shifted from 2.0 to 2.4ppm; for the second one no chemical shift difference was measured. For the proton signals of all the other aminoacids in lc no significant changes were observed in comparison to the XHNMRspectrum of CyA. In the 13C NMRspectrum, a new singlet at S 68.87 ppm confirmed the 4-y-hydroxy substitution. On the basis of these data lc was identified as [yHyMeLeu4]-CyA. This derivative could not be detected in human urine, but a similar metabolite carrying an additional hydroxy group in y-position of amino acid 9X\ was formed. AUG. 1996 Further biotransformation products of CyA, obtained Although the main human metabolite OL-17 was not produced by Sebekia benihana, it could be detected as a minor transformation derivative of ll fungi and 3 bacteria ( Table 1 and also recently found as a natural minor metabolite1 6).
The 1H NMRspectrum of li showed a new doublet at 3 6.2ppm, which was assigned to the 9-amide proton. This doublet replaced the singlet of the iV-methyl protons at S 3.1 ppm ofMeLeu9 in the XHNMRspectrum of CyA. The Af-demethylation at the amino acid 9 was further confirmed by COSY, ROESY (Fig. 3) and TOCSY experiments. Coincidently with our work,
[Leu9]CyA was described as a new memberof the cyclosporin group isolated from the fungus1 7). lb and lh are the only microbial biotransformation derivatives detected in the screening, which are identical to the corresponding human metabolites of CyA. Whereas the cytochrome P-450 mechanism resembles the chemical oxidation by hypervalent transition metal oxidants, the Flavine-dependent mechanism parallels the oxidation of organic compounds by peroxides18). Table 2 ). This fact may be a possible reason for the reduced biological effects of the microbial transformation products in respect to CyA. On the other hand, the higher polarity of these derivatives may be advantageous for improved pharmacokinetic attributes. Furthermore, hydroxylated derivatives easier attainable AUG. 1996 by biotransformation than by chemical methods, may serve as starting materials for the synthesis of new products.
